Understanding COVID-19 vaccine efficacy

Vaccine efficacy in high-risk groups and reduced viral shedding are important for protection The elderly and people with comorbidities are at greatest risk of severe coronavirus disease 2019 (COVID-19). A safe and effective vaccine could help to protect these groups in two distinct ways: direct prot...

Full description

Saved in:
Bibliographic Details
Published in:Science 2020-11, Vol.370 (6518), p.763-765
Main Authors: Lipsitch, Marc, Dean, Natalie E.
Format: Article
Language:English
Subjects:
Age Factors
Betacoronavirus - immunology
Betacoronavirus - physiology
Clinical Laboratory Techniques
Clinical Trials, Phase III as Topic
Coronavirus Infections - diagnosis
Coronavirus Infections - immunology
Coronavirus Infections - prevention & control
Coronavirus Infections - transmission
Coronavirus Infections - virology
Coronaviruses
COVID-19
COVID-19 Testing
COVID-19 Vaccines
Disease control
Disease transmission
Humans
Immune response
Influenza
Observational Studies as Topic
Older people
Pandemics - prevention & control
PERSPECTIVES
Pneumonia, Viral - immunology
Pneumonia, Viral - prevention & control
Pneumonia, Viral - transmission
Pneumonia, Viral - virology
Randomized Controlled Trials as Topic
Risk
Risk groups
SARS-CoV-2
Vaccination
Vaccine efficacy
Vaccines
Viral diseases
Viral Load
Viral Vaccines - administration & dosage
Viral Vaccines - adverse effects
Viral Vaccines - immunology
Virus Shedding
Young adults
Citations: Items that this one cites
Items that cite this one
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!